OSLO, Norway, June 22, 2021 /PRNewswire/ -- Photocure ASA (OSE:PHO) today announces that its partner Asieris Pharmaceuticals (Asieris) has administered the first European patient in its phase III clinical trial for APL-1702 (Cevira®). Asieris announced dosing of the first patient in...
from PR Newswire: https://ift.tt/35L78IO
No comments:
Post a Comment